Skip to main content
360 ONE WAM LIMITED logo

360 ONE WAM LIMITED — Investor Relations & Filings

Ticker · 360ONE ISIN · INE466L01038 LEI · 335800DDYMCDBO5OLL32 BSE.NS Financial and insurance activities
Filings indexed 894 across all filing types
Latest filing 2026-01-23 Share Issue/Capital Cha…
Country IN India
Listing BSE.NS 360ONE

About 360 ONE WAM LIMITED

https://www.360.one/

360 ONE WAM LIMITED is a specialized wealth and asset management firm providing comprehensive financial solutions to high-net-worth and ultra-high-net-worth individuals, family offices, and institutional investors. The company offers a diverse range of services, including investment advisory, portfolio management, and estate planning. Its product suite encompasses alternative investment funds, mutual funds, and structured products, alongside specialized lending solutions against financial assets. By leveraging a technology-led approach and deep domain expertise, the firm focuses on capital preservation and long-term wealth creation. The organization operates through integrated platforms to deliver customized investment strategies and holistic financial planning, catering to the complex needs of sophisticated global and domestic clients.

Recent filings

Filing Released Lang Actions
ESOP/ESOS/ESPS
Share Issue/Capital Change Classification · 100% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) informing about the allotment of equity shares upon exercise of Employee Stock Options (ESOPs). It details the increase in issued share capital due to this allotment. The content is an announcement of a capital change event, specifically the allotment of shares, rather than a financial report or regulatory filing about financial results or governance. The document length is short (1697 characters), and it is a direct notification of a share capital change. Therefore, the appropriate classification is 'Share Issue/Capital Change' (SHA).
2026-01-23 English
News Verification
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India regarding a clarification on a news article about a fund raising event. It explicitly states that no press release was made about the news item and clarifies the ongoing nature of the fund scheme. The document is a regulatory clarification letter responding to an inquiry, not a financial report or announcement of results. It does not contain financial statements, earnings data, or detailed report content. The length is short (3154 characters), and it serves as a regulatory disclosure or clarification under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Therefore, it fits best under Regulatory Filings (RNS) as a compliance disclosure rather than a report or announcement of financial results or capital changes.
2026-01-21 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of an earnings call held on January 15, 2026, discussing the company's financial performance for the quarter and nine months ended December 31, 2025. It includes remarks from the CEO, CFO, and other executives, covering financial results, business updates, strategic initiatives, and outlook. The document explicitly states it is a transcript of the earnings call and contains substantive financial data and management commentary. Therefore, it fits the definition of a Call Transcript (CT).
2026-01-20 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) informing them about the schedule of upcoming analyst and institutional investor meetings. It references discussions about the investor presentation for the quarter and nine months ended December 31, 2025, which is available on the company's website and stock exchanges. The document does not contain the investor presentation itself, nor does it include financial data or detailed analysis. It is essentially an announcement of scheduled investor meetings and the availability of a related presentation elsewhere. The document length is short (2837 characters), and it serves as an informational notice rather than a report or transcript. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2026-01-16 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) informing them about the schedule of upcoming analyst and institutional investor meetings. It references discussions about the investor presentation for the quarter and nine months ended December 31, 2025, which is available on the company's website and stock exchanges. The document does not contain the investor presentation itself, nor does it include financial data or detailed analysis. It is essentially an announcement of scheduled investor meetings and the availability of a presentation elsewhere. The document length is short (2837 characters), and it serves as an intimation rather than a report or transcript. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2026-01-16 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) informing about the schedule of upcoming analyst and institutional investor meetings. It references discussions about the investor presentation for the quarter and nine months ended December 31, 2025, but does not contain the presentation or financial data itself. The document is short (2837 characters) and serves as an announcement of scheduled investor meetings rather than the report or presentation itself. There is no detailed financial data or analysis included. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement informing the market about upcoming investor interactions, not the investor presentation or financial report itself.
2026-01-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.